Men with longer exposure to the drugs finasteride and dutasteride had a higher risk of getting persistent erectile dysfunction than those with less exposure, researchers from Northwestern University in the US said.
The persistent erectile dysfunction continued despite stopping these drugs, in some cases for months or years.
Among young men, prolonged exposure to the drugs posed a greater risk of persistent erectile dysfunction (PED) than all other assessed risk factors.
Erectile dysfunction is difficulty achieving and maintaining a sufficient erection to have sex. Persistent erectile dysfunction continued despite stopping the drug and continued despite taking sildenafil (Viagra) or similar drug.
Also Read
Prior to the new study, there was no strong evidence that finasteride and dutasteride cause sexual problems that continue after men stop taking them, researchers said.
There also was no strong evidence that taking these drugs for a longer time increases the chance of experiencing sexual problems, they said.
Finasteride and dutasteride are drugs that are male hormone blockers. These drugs block the conversion of testosterone to its more active form, 5 alpha dihydrotestosterone.
Finasteride is prescribed to some men with prostate enlargement or baldness. Dutasteride is prescribed to some men with prostate enlargement.
Propecia and Proscar are brand names for finasteride. Avodart is a brand name for dutasteride. Jalyn is a combination drug containing dutasteride and tamsulosin.
Among the men studied, 167 of 11,909 (1.4 per cent) developed persistent erectile dysfunction that continued for a median of 1,348 days after stopping the drugs.
Young men under 42 years old who had more than 205 days of finasteride or dutasteride exposure had 4.9-fold higher risk of persistent erectile dysfunction than men with shorter exposure, researchers found.
The study was published in the journal PeerJ.
Disclaimer: No Business Standard Journalist was involved in creation of this content